These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Human skin microbiota-friendly lysostaphin. Bonar E; Bukowski M; Chlebicka K; Madry A; Bereznicka A; Kosecka-Strojek M; Dubin G; Miedzobrodzki J; Mak P; Wladyka B Int J Biol Macromol; 2021 Jul; 183():852-860. PubMed ID: 33932416 [TBL] [Abstract][Full Text] [Related]
27. Differential binding of human and murine IgGs to catalytic and cell wall binding domains of Staphylococcus aureus peptidoglycan hydrolases. Wang M; van den Berg S; Mora Hernández Y; Visser AH; Vera Murguia E; Koedijk DGAM; Bellink C; Bruggen H; Bakker-Woudenberg IAJM; van Dijl JM; Buist G Sci Rep; 2021 Jul; 11(1):13865. PubMed ID: 34226629 [TBL] [Abstract][Full Text] [Related]
28. Lysostaphin as a treatment for systemic Staphylococcus aureus infection in a mouse model. Kokai-Kun JF; Chanturiya T; Mond JJ J Antimicrob Chemother; 2007 Nov; 60(5):1051-9. PubMed ID: 17848374 [TBL] [Abstract][Full Text] [Related]
29. A Novel Chimeric Endolysin with Antibacterial Activity against Methicillin-Resistant Haddad Kashani H; Fahimi H; Dasteh Goli Y; Moniri R Front Cell Infect Microbiol; 2017; 7():290. PubMed ID: 28713777 [TBL] [Abstract][Full Text] [Related]